Dendritic cells subsets detection in peripheral blood in patients with multiple myeloma during treatment and after transplantation
Hajek, R.; Doubek, M.; Kovarova, L.; Bourkova, L.; Fiserova, A.; Musilova, R.; Klabusay, M.; Bulikova, A.; Vorlicek, J.; Penka, M.
Experimental Hematology 29(8 Suppl 1): 27
2001
ISSN/ISBN: 0301-472X Accession: 034695270
PDF emailed within 1 workday: $29.90
Related References
Liso, A.; Stockerl-Goldstein, K.E.; Auffermann-Gretzinger, S.; Benike, C.J.; Reichardt, V.; van Beckhoven, A.; Rajapaksa, R.; Engleman, E.G.; Blume, K.G.; Levy, R. 2000: Idiotype vaccination using dendritic cells after autologous peripheral blood progenitor cell transplantation for multiple myeloma Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 6(6): 621-627Boumsell, L.; Malphettes, M.; Bolton, W.; Roth, R.; Kuentz, M.; Fermand, J.P.; Autran, B.; Divine, M. 1998: Lymphocyte subsets recovery after autologous transplantation of CD34+ peripheral blood progenitor cells in patients with advanced non Hodgkins lymphoma or multiple myeloma Cytometry (Suppl 9): 98
Reichardt, V.; Okada, C.; Benike, C.; Long, G.; Engleman, E.; Blume, K.; Levy, R. 1996: Idiotypic vaccination using dendritic cells for multiple myeloma patients after autologous peripheral blood stem cell transplantation Blood 88(10 Suppl 1 Part 1-2): 481A
Reichardt, V.L.; Okada, C.Y.; Liso, A.; Benike, C.J.; Stockerl-Goldstein, K.E.; Engleman, E.G.; Blume, K.G.; Levy, R. 1999: Idiotype vaccination using dendritic cells after autologous peripheral blood stem cell transplantation for multiple myeloma--a feasibility study Blood 93(7): 2411-2419
García Laraña, J.; Díaz Mediavilla, J.; Martínez, R.; Lahuerta, J.J.; Alegre, A.; Odriozola, J.; Sureda, A.; San Miguel, J.; De la Rubia, J.; Escudero, A.; Conde, E.; Bladé, J.; Cabrera, R.; Gastearena, J.; Besalduch, J.; Vidal, M.J.; Hernández, F.; Rifon, J.; Leon, A.; Mataix, R.; Parody, R.; Moraleda, J.M.; Solano, C.; de Pablos, J.M.; Sánchez, J.J. 1997: Maintenance treatment with interferon-alfa in multiple myeloma after autotransplantation of peripheral blood progenitor cells. Spanish Register of Transplantation in Myeloma Sangre 42(Suppl 1): 38-41
Vela-Ojeda, J.; García-Ruiz Esparza, M.A.; Reyes-Maldonado, E.; Jiménez-Zamudio, L.; García-Latorre, E.; Moreno-Lafont, M.; Estrada-García, I.; Mayani, H.; Montiel-Cervantes, L.; Tripp-Villanueva, F.; Ayala-Sánchez, M.; García-León, L.D.; Borbolla-Escoboza, J.R. 2006: Peripheral blood mobilization of different lymphocyte and dendritic cell subsets with the use of intermediate doses of G-CSF in patients with non-Hodgkin's lymphoma and multiple myeloma Annals of Hematology 85(5): 308-314
Kovarova, L.; Svobadnik, A.; Buchler, T.; Klabusay, M.; Hajek, R. 2002: Dendritic cells numbers and their subsets during the treatment in multiple myeloma Experimental Hematology (Charlottesville) 30(6 Suppl 1): 111
Raje, N.; Gong, J.; Chauhan, D.; Teoh, G.; Avigan, D.; Wu, Z.; Chen, D.; Treon, S.P.; Webb, I.J.; Kufe, D.W.; Anderson, K.C. 1999: Bone marrow and peripheral blood dendritic cells from patients with multiple myeloma are phenotypically and functionally normal despite the detection of Kaposi's sarcoma herpesvirus gene sequences Blood 93(5): 1487-1495
Schiller, G.; Vescio, R.; Lee, M.; Bearman, S.; Spitzer, G.; Freytes, C.; Lill, M.; Berenson, R.; Berenson, J. 1993: Transplantation of autologous CD34-positive peripheral blood stem cells as treatment for multiple myeloma Blood 82(10 Suppl 1): 198A
Huang, L.-Q.; Wang, J.-X.; He, K.; Jiang, Y.-Z.; Wei, Z.-L.; Huang, D.-P.; Chu, L.-L. 2018: Analysis of peripheral blood T-cell subsets and regulatory T-cells in multiple myeloma patients Cellular and Molecular Biology 64(5): 113-117
Tribalto, M.; Adorno, G.; Bugliosi, R.; Caravita, T.; Coppetelli, U.; Cudillo, L.; Del Poeta, G.; Dentamaro, T.; Avvisati, G.; La Verde, G.; Meloni, G.; Leone, G.; Menichella, G.; Martelli, M.; Tabilio, A.; Fioritoni, G.; Iacone, P.; Majolino, I.; Scime, R.; Mandelli, F. 1994: Autologous peripheral blood stem cells transplantation as first line treatment for multiple myeloma An Italian multicentric pilot study Blood 84(10 Suppl 1): 181A
Shi, L.-L.; Li, H.-Q.; Mei, J.-G.; Zhou, X.-G.; Li, F.; Song, P.; Zhai, Y.-P. 2018: Effect and Clinical Significance of Bortezomib and Thalidomide on the Memory T Cells Subsets and Regulatory T Cells in Peripheral Blood of Patients with Multiple Myeloma Zhongguo Shi Yan Xue Ye Xue Za Zhi 26(2): 477-483
Richens, J.; Fairclough, L.; Ghaemmaghami, A.M.; Mahdavi, J.; Shakib, F.; Sewell, H.F. 2007: The detection of ADAM8 protein on cells of the human immune system and the demonstration of its expression on peripheral blood B cells, dendritic cells and monocyte subsets Immunobiology 212(1): 29-38
López-Pérez, R.; García-Sanz, R.; González, D.; Balanzategui, A.; Chillón, M.C.; Alaejos, I.; Mateos, M.V.; Caballero, M.D.; Mateo, G.; Nieto, M.J.; González, M.; San Miguel, J.F. 2000: The detection of contaminating clonal cells in apheresis products is related to response and outcome in multiple myeloma undergoing autologous peripheral blood stem cell transplantation Leukemia 14(8): 1493-1499
Rottenburger, C.; Kiel, K.; Bösing, T.; Cremer, F.W.; Moldenhauer, G.; Ho, A.D.; Goldschmidt, H.; Moos, M. 1999: Clonotypic CD20+ and CD19+ B cells in peripheral blood of patients with multiple myeloma post high-dose therapy and peripheral blood stem cell transplantation British Journal of Haematology 106(2): 545-552